Compared to Estimates, Ventas (VTR) Q4 Earnings: A Look at Key Metrics
Werte in diesem Artikel
Ventas (VTR) reported $1.29 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 10.5%. EPS of $0.81 for the same period compares to -$0.21 a year ago.The reported revenue represents a surprise of +2.23% over the Zacks Consensus Estimate of $1.26 billion. With the consensus EPS estimate being $0.80, the EPS surprise was +1.25%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Ventas performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Rental income- Outpatient medical & research portfolio: $216.20 million versus $220.75 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -2.6% change. Revenues- Rental income- Triple-net leased: $157.40 million versus $151.56 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +1.4% change. Revenues- Resident fees and services: $896.36 million versus $850.11 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +15.6% change. Revenues- Rental income: $373.60 million versus the four-analyst average estimate of $372.31 million. Revenues- Third party capital management revenues: $4.34 million compared to the $4.63 million average estimate based on three analysts. The reported number represents a change of -0.3% year over year. Revenues- Interest and other income: $8.31 million versus $5.60 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +41.1% change. Revenues- Income from loans and investments: $4.45 million versus $2.56 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +178% change. Net Earnings Per Share (Diluted): $0.13 compared to the $0.06 average estimate based on five analysts. View all Key Company Metrics for Ventas here>>>Shares of Ventas have returned +2.5% over the past month versus the Zacks S&P 500 composite's +4.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ventas, Inc. (VTR): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Q4
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Ventas Inc.
Analysen zu Ventas Inc.
Datum | Rating | Analyst | |
---|---|---|---|
03.09.2019 | Ventas Equal Weight | Barclays Capital | |
04.05.2018 | Ventas Market Perform | BMO Capital Markets | |
22.03.2017 | Ventas Hold | SunTrust | |
21.11.2016 | Ventas Neutral | Mizuho | |
13.07.2016 | Ventas Hold | Argus Research Company |
Datum | Rating | Analyst | |
---|---|---|---|
04.05.2018 | Ventas Market Perform | BMO Capital Markets | |
06.07.2016 | Ventas Buy | Mizuho | |
05.04.2016 | Ventas Buy | Mizuho | |
03.03.2016 | Ventas Buy | Mizuho | |
15.01.2016 | Ventas Market Perform | BMO Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
03.09.2019 | Ventas Equal Weight | Barclays Capital | |
22.03.2017 | Ventas Hold | SunTrust | |
21.11.2016 | Ventas Neutral | Mizuho | |
13.07.2016 | Ventas Hold | Argus Research Company | |
02.05.2016 | Ventas Equal Weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
24.05.2010 | Ventas "underperform" | Robert W. Baird & Co. Incorporated |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ventas Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen